Literature DB >> 19640180

Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country.

G H Tan1, Nur Aishah Taib, W Y Choo, S H Teo, Cheng Har Yip.   

Abstract

INTRODUCTION: Triple negative (TN) breast cancers are defined by a lack of expression of oestrogen, progesterone, and HER2 receptors. They tend to have a higher grade, with a poorer outcome compared to non-TN breast cancers.
OBJECTIVE: The aim of this study is to determine the incidence of TN breast cancer in an Asian country consisting of Malays, Chinese and Indians, and to determine the factors associated with this type of breast cancer.
RESULTS: The incidence of TN breast cancer in the University Malaya Medical Center is 17.6%. There is no significant difference amongst the Malays, Chinese and Indians. In bivariate analysis, TN breast cancer was significantly associated with younger age and Grade 3. However, in multivariate analysis using logistic regression, TN breast cancer was only associated with Grade 3.
CONCLUSION: The incidence of TN breast cancer in our study is similar to other studies, and associated with a higher grade.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640180

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  Immunohistochemical profile and morphology in triple - negative breast cancers.

Authors:  Chandrika Rao; Jayaprakash Shetty; Kishan Hl Prasad
Journal:  J Clin Diagn Res       Date:  2013-05-28

2.  Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.

Authors:  S Subramaniam; N Bhoo-Pathy; N A Taib; G H Tan; M H See; S Jamaris; G F Ho; L M Looi; C H Yip
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

3.  Regulation of Cellular and Cancer Stem Cell-Related Putative Gene Expression of Parental and CD44+CD24- Sorted MDA-MB-231 Cells by Cisplatin.

Authors:  May Zie Koh; Wan Yong Ho; Swee Keong Yeap; Norlaily Mohd Ali; Lily Boo; Noorjahan Banu Alitheen
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-21

4.  Hormone receptors and age distribution in breast cancer patients at a university hospital in northern egypt.

Authors:  Osama Hussein; Mahmoud Mosbah; Omar Farouk; Kamel Farag; Aiman El-Saed; Mohammad Arafa; Ahmed Abdallah
Journal:  Breast Cancer (Auckl)       Date:  2013-06-12

5.  Ultrasound and clinicopathological characteristics of triple receptor-negative breast cancers.

Authors:  Yoon Jung Choi; Min Hyun Seong; Seon Hyeong Choi; Shin Ho Kook; Hyon Joo Kwag; Yong Lai Park; Chan Heun Park
Journal:  J Breast Cancer       Date:  2011-06-18       Impact factor: 3.588

6.  Correlation of CK5 and EGFR with Clinicopathological Profile of Triple-Negative Breast Cancer.

Authors:  Neelam Sood; Jitendra Singh Nigam
Journal:  Patholog Res Int       Date:  2014-10-23

7.  Increased Tumour Infiltration of CD4+ and CD8+ T-Lymphocytes in Patients with Triple Negative Breast Cancer Suggests Susceptibility to Immune Therapy

Authors:  Bushra Sikandar; Muhammad Asif Qureshi; Saima Naseem; Saeed Khan; Talat Mirza
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

8.  Clinical Characteristics in Patients with Triple Negative Breast Cancer.

Authors:  Janet Yeh; Jennifer Chun; Shira Schwartz; Annie Wang; Elizabeth Kern; Amber A Guth; Deborah Axelrod; Richard Shapiro; Freya Schnabel
Journal:  Int J Breast Cancer       Date:  2017-08-17

9.  A Novel Subset of Triple-Negative Breast Cancers with Unique Histology and Immunohistochemical Expression.

Authors:  Swaminathan Kalyanasundaram; Shantaraman Kalyanaraman; Hidhaya Kaleelullah Fathima; Vidhya Mohan; Kavitha Selvaraj
Journal:  Iran J Pathol       Date:  2022-03-08

10.  Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women.

Authors:  Shant Kishen Kanapathy Pillai; Annie Tay; Suseela Nair; Chee-Onn Leong
Journal:  BMC Clin Pathol       Date:  2012-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.